HOUSTON & BOSTON--(BUSINESS WIRE)--Stem Cell Innovations, Inc. (OTCBB:SCLL) announced today that the Company will collaborate with Massachusetts Eye and Ear Infirmary (MEEI). MEEI is an international leader in Ophthalmology and Otolaryngology research and a teaching partner of Harvard Medical School. Under the material transfer agreement, MEEI will evaluate PluriCells™ for their capacity to form the human tissues implicated in hearing loss. In return SCI will receive a nonexclusive license to intellectual property generated using the PluriCells.
